SMN2 and proximal spinal muscular atrophy: Small ASOs targeting a GC-rich sequence overlapping ISS-N1 also promote SMN2 exon 7 inclusion and provide therapeutic benefits in mouse models of SMA (Singh et al., 2009, 2015b; Sivanesan et al., 2013; Kiel et al., 2014).